AC Immune

Alzheimer's Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics

Feb 25, 2025

Alzheimer’s Disease: Navigating the Rising Incidence, Evolving Treatments, and Market Dynamics

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune

Sep 07, 2021

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

recent-pharma-happenings-for-j-j-anokion-bms-roche

Sep 24, 2020

J&J ‘s COVID-19 vaccine; Roche, AC Immune’s anti-Tau Alzheimer’s drug; Silverback nets $85 M; Anokion’s deal rides out BMS-Celgene merger; Coronavirus spike protein could inspire vaccine development

alzheimer's

Dec 13, 2018

Lilly remunerates AC Immune; Akero adds $70M; Ra Pharma $100M

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper